Clinical Pathway

Referral to treatment National Optimal Lung Cancer Pathway For suspected and confirmed lung cancer: Referral to treatment UPDATE 2017 Version 2.0 Start pathway View the flowchart Read more
NSCLC Clinical Stage IA and IB Start pathway View the flowchart Read more
NSCLC Clinical Stage IIA, IIB and Resectable IIIA Excluding Pancoast Tumors for Patients Who Have Not Received Neoadjuvant Treatment Start pathway View the flowchart Read more
NSCLC Clinically Resectable Stage IIA, IIB, and IIIA Excluding Pancoast Tumors Start pathway View the flowchart Read more
NSCLC Clinically Resectable Stage IIA, IIB, and IIIA Excluding Pancoast Tumors Start pathway View the flowchart Read more
NSCLC Clinical Stage III Unresectable Multiple Level N2, Bulky N2, Any N3, Any T4 Due To Tumor Invasion Into Adjacent Structure First Line Start pathway View the flowchart Read more
NSCLC Stage IVA M1b Single Extrathoracic Site or M1a Due To A Contralateral Nodule at Presentation Start pathway View the flowchart Read more
Molecular Testing Start pathway View the flowchart Read more
NSCLC Stage IVA Due to Pericardial/Pleural Effusion and IVB Mutation Positive Start pathway View the flowchart Read more
NSCLC Stage IVA Due to Pericardial/Pleural Effusion and IVB Mutation Negative Start pathway View the flowchart Read more